“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
U.S. to open military ties soon with Myanmar: official
Feds: Cop Pulled Over Female Drivers To Look At Their Breasts
Supreme Court rules that states can shake down out-of-state online sellers
Mom faces arrest after bringing breast-fed newborn to jury duty
Catholic Priest Allegedly Beheaded in Syria by Al-Qaeda-Linked Rebels Who Take Pictures and Cheer
Cop suspended for sex with teen, hosting underage drinking parties
Switzerland and Britain are now at currency war
Angry Birds, 'leaky' phone apps targeted for user data by NSA, GCHQ
FBI ‘Grappling’ With Hiring Policy Because Top Hackers Smoke Pot
Big tobacco stubs out e-cigarette competitors
Critics question IRS cash-reporting initiative targeting small businesses
Postal Service losses tripled to $16 billion from previous year
Americans’ personal data shared with CIA, IRS, others in security probe
Thousands of heavily armed police swarm Boston town in bombing suspect manhunt
Edward Snowden, NSA whistleblower: 'I do not expect to see home again'